Frontiers in Clinical Drug Research Anti-Cancer Agents/ (Record no. 157668)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01478nam a2200205Ia 4500 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OSt |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20220322141500.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 210614s9999 xx 000 0 und d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 978-981-14-7841-3 |
040 ## - CATALOGING SOURCE | |
Transcribing agency | LC |
100 ## - MAIN ENTRY--PERSONAL NAME | |
Personal name | Atta-ur-Rahman, FRS |
Relator code | Editor |
245 #0 - TITLE STATEMENT | |
Title | Frontiers in Clinical Drug Research Anti-Cancer Agents/ |
Statement of responsibility, etc | Atta-ur-Rahman, FRS |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Place of publication, distribution, etc | UAE: |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Name of publisher, distributor, etc | Bentham Science Publisher, |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
Date of publication, distribution, etc | 2021. |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 292 pages |
440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
Volume number/sequential designation | Vol. 6 |
520 ## - SUMMARY, ETC. | |
Summary, etc | Frontiers in Clinical Drug Research - Anti-Cancer Agents is a book series intended for pharmaceutical scientists, postgraduate students and researchers seeking updated and critical information for developing clinical trials and devising research plans in anti-cancer research. Reviews in each volume are written by experts in medical oncology and clinical trials research and compile the latest information available on special topics of interest to oncology and pharmaceutical chemistry researchers. The sixth volume of the book features reviews on these topics: · Immunomodulating Agents in The Treatment of Acute Myeloid Leukemia · Potential Natural Products for Prostate Cancer Management · Inhibition of Key Protein-Protein Interactions by Small Molecules for Cancer Drug Design · Efficacy of Hepatic Arterial Infusion Chemotherapy (HAIC) For Advanced Hepatocellular Carcinoma · Targeting Cancer Stem Cells: Implications in Health and Disease |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Koha item type | Book |
Source of classification or shelving scheme | Library of Congress Classification |
Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Home library | Current library | Date acquired | Total Checkouts | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Library of Congress Classification | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) Library | 22/03/2022 | RM301.27.F76_2021 | P 2980 | 22/03/2022 | 22/03/2022 | Book |